Pay in 4 interest-free payments of $7.29 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
10.1038/s41572-018-0004-9 16 ChatterjeeP
We have strict technical, physical, and administrative safeguards to protect the Personal Information that we collect
Researchers analyze its structure and peptide-related interactions within experimental research models
METAOD005: A Phase IIb (randomized, double-blind, placebo-controlled) study to assess the efficacy (reduction in body weight), safety and tolerability of 12 weeks treatment with daily doses (1, 5, 10, 20 or 30 mg AOD9604) administered orally (capsules) in 300 healthy, clinically obese males, and females of non-child bearing potential, with a BMI 35 kg/m 2
BPC-157 is not FDA-approved for any medical use
Seek professional medical evaluation and treatment from a licensed provider
US$ 24.80
US$ 25.67
US$ 22.54
US$ 24.84
US$ 22.84
US$ 25.57
